Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quasar Distributors, LLC is a leading financial services firm that provides distribution, underwriting, and compliance solutions for mutual funds and exchange-traded funds (ETFs). As a FINRA-registered broker-dealer and a subsidiary of ACA Group, the company serves as the legal distributor for a wide array of investment products, including several prominent biotechnology and life science-focused funds. While not a drug developer itself, Quasar is a critical service provider in the healthcare investment ecosystem, facilitating the market presence of sector-specific ETFs such as the Virtus LifeSci Biotech Clinical Trials ETF (BBC) and the Loncar Cancer Immunotherapy ETF (CNCR). Its services ensure that fund managers remain compliant with regulatory standards while reaching institutional and retail investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quasar Distributors.